Circulating Tumor DNA as Marker of Therapeutic Efficacy in Breast Cancer Patients

Condition:   Breast Neoplasms Intervention:   Other: ctDNA level during neoadjuant chemotherapy Sponsor:   First Affiliated Hospital Xi'an Jiaotong University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials